<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35043381</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>26</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-3524</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Neurotoxicity research</Title><ISOAbbreviation>Neurotox Res</ISOAbbreviation></Journal><ArticleTitle>The Gpx4NIKO Mouse Is a Versatile Model for Testing Interventions Targeting Ferroptotic Cell Death of Spinal Motor Neurons.</ArticleTitle><Pagination><StartPage>373</StartPage><EndPage>383</EndPage><MedlinePgn>373-383</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12640-021-00469-0</ELocationID><Abstract><AbstractText>The degeneration and death of motor neurons lead to motor neuron diseases such as amyotrophic lateral sclerosis (ALS). Although the exact mechanism by which motor neuron degeneration occurs is not well understood, emerging evidence implicates the involvement of ferroptosis, an iron-dependent oxidative mode of cell death. We reported previously that treating Gpx4NIKO mice with tamoxifen to ablate the ferroptosis regulator glutathione peroxidase 4 (GPX4) in neurons produces a severe paralytic model resembling an accelerated form of ALS that appears to be caused by ferroptotic cell death of spinal motor neurons. In this study, in support of the role of ferroptosis in this model, we found that the paralytic symptoms and spinal motor neuron death of Gpx4NIKO mice were attenuated by a chemical inhibitor of ferroptosis. In addition, we observed that the paralytic symptoms of Gpx4NIKO mice were malleable and could be tapered by lowering the dose of tamoxifen, allowing for the generation of a mild paralytic model without a rapid onset of death. We further used both models to evaluate mitochondrial reactive oxygen species (mtROS) in the ferroptosis of spinal motor neurons and showed that overexpression of peroxiredoxin 3, a mitochondrial antioxidant defense enzyme, ameliorated symptoms of the mild but not the severe model of the Gpx4NIKO mice. Our results thus indicate that the Gpx4NIKO mouse is a versatile model for testing interventions that target ferroptotic death of spinal motor neurons in vivo.</AbstractText><CopyrightInformation>&#xa9; 2022. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Evans</LastName><ForeName>Robert Cole</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>Department of Cell Systems &amp; Anatomy, University of Texas Health San Antonio, San Antonio, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Liuji</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Cell Systems &amp; Anatomy, University of Texas Health San Antonio, San Antonio, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Na</LastName><ForeName>Ren</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cell Systems &amp; Anatomy, University of Texas Health San Antonio, San Antonio, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoo</LastName><ForeName>Kwangsun</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Cell Systems &amp; Anatomy, University of Texas Health San Antonio, San Antonio, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ran</LastName><ForeName>Qitao</ForeName><Initials>Q</Initials><Identifier Source="ORCID">0000-0002-2127-8349</Identifier><AffiliationInfo><Affiliation>Department of Cell Systems &amp; Anatomy, University of Texas Health San Antonio, San Antonio, TX, USA. ran@uthscsa.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Service, South Texas Veterans Health Care System, San Antonio, TX, USA. ran@uthscsa.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>AG064078</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>I01 BX003507</GrantID><Acronym>BX</Acronym><Agency>BLRD VA</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 NS082145</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG064078</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>Merit Review Award I01 BX003507</GrantID><Agency>U.S. Department of Veterans Affairs</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neurotox Res</MedlineTA><NlmUniqueID>100929017</NlmUniqueID><ISSNLinking>1029-8428</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>094ZI81Y45</RegistryNumber><NameOfSubstance UI="D013629">Tamoxifen</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.11.1.12</RegistryNumber><NameOfSubstance UI="D000080662">Phospholipid Hydroperoxide Glutathione Peroxidase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016923" MajorTopicYN="N">Cell Death</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000080662" MajorTopicYN="N">Phospholipid Hydroperoxide Glutathione Peroxidase</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013629" MajorTopicYN="N">Tamoxifen</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Ferroptosis</Keyword><Keyword MajorTopicYN="N">Glutathione peroxidase 4</Keyword><Keyword MajorTopicYN="N">Mitochondrial reactive oxygen species</Keyword><Keyword MajorTopicYN="N">Motor neuron degeneration</Keyword><Keyword MajorTopicYN="N">Peroxiredoxin 3</Keyword></KeywordList><CoiStatement>Conflicts of interest/Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>12</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>19</Day><Hour>7</Hour><Minute>7</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35043381</ArticleId><ArticleId IdType="mid">NIHMS1776048</ArticleId><ArticleId IdType="pmc">PMC9035057</ArticleId><ArticleId IdType="doi">10.1007/s12640-021-00469-0</ArticleId><ArticleId IdType="pii">10.1007/s12640-021-00469-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abdalkader M, Lampinen R, Kanninen KM, Malm TM, Liddell JR (2018) Targeting Nrf2 to suppress ferroptosis and mitochondrial dysfunction in neurodegeneration. Front Neurosci 12:1&#x2013;9. 10.3389/fnins.2018.00466</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00466</ArticleId><ArticleId IdType="pmc">PMC6048292</ArticleId><ArticleId IdType="pubmed">30042655</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber SC, Shaw PJ (2010) Oxidative stress in ALS: key role in motor neuron injury and therapeutic target. Free Radic Biol Med 48:629&#x2013;641. 10.1016/j.freeradbiomed.2009.11.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2009.11.018</ArticleId><ArticleId IdType="pubmed">19969067</ArticleId></ArticleIdList></Reference><Reference><Citation>Battaglia AM, Chirillo R, Aversa I, Sacco A, Costanzo F, Biamonte F (2020) Ferroptosis and cancer: mitochondria meet the &#x201c;iron maiden&#x201d; cell death. Cells 9:1&#x2013;26. 10.3390/cells9061505</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9061505</ArticleId><ArticleId IdType="pmc">PMC7349567</ArticleId><ArticleId IdType="pubmed">32575749</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Hambright WS, Na R, Ran Q (2015) Ablation of the Ferroptosis Inhibitor Glutathione Peroxidase 4 in Neurons Results in Rapid Motor Neuron Degeneration and Paralysis. J Biol Chem 290:28097&#x2013;28106. 10.1074/jbc.M115.680090</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.680090</ArticleId><ArticleId IdType="pmc">PMC4653669</ArticleId><ArticleId IdType="pubmed">26400084</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Na R, Gu M, Salmon AB, Liu Y, Liang H, Qi W, Van Remmen H, Richardson A, Ran Q (2008) Reduction of mitochondrial H2O2 by overexpressing peroxiredoxin 3 improves glucose tolerance in mice. Aging Cell 7:866&#x2013;878. 10.1111/j.1474-9726.2008.00432.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1474-9726.2008.00432.x</ArticleId><ArticleId IdType="pmc">PMC4431549</ArticleId><ArticleId IdType="pubmed">18778410</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Na R, McLane KD, Thompson CS, Gao J, Wang X, Ran Q (2021) Overexpression of ferroptosis defense enzyme Gpx4 retards motor neuron disease of SOD1G93A mice. Sci Rep 11:1&#x2013;13. 10.1038/s41598-021-92369-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-92369-8</ArticleId><ArticleId IdType="pmc">PMC8213805</ArticleId><ArticleId IdType="pubmed">34145375</ArticleId></ArticleIdList></Reference><Reference><Citation>Devos D, Moreau C, Kyheng M, Gar&#xe7;on G, Rolland AS, Blasco H, Gel&#xe9; P, Lenglet TT, Veyrat-Durebex C, Corcia P, Dutheil M, Bede P, Jeromin A, Oeckl P, Otto M, Meininger V, Danel-Brunaud V, Devedjian J, Duce JA, Pradat PF (2019) A ferroptosis-based panel of prognostic biomarkers for Amyotrophic Lateral Sclerosis. Sci Rep 9:1&#x2013;6. 10.1038/s41598-019-39739-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-39739-5</ArticleId><ArticleId IdType="pmc">PMC6393674</ArticleId><ArticleId IdType="pubmed">30814647</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, Morrison B III, B.R. Stockwell BR (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149:1060&#x2013;1072. 10.1016/j.cell.2012.03.042</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2012.03.042</ArticleId><ArticleId IdType="pmc">PMC3367386</ArticleId><ArticleId IdType="pubmed">22632970</ArticleId></ArticleIdList></Reference><Reference><Citation>Do VB, Gouel F, Jonneaux A, Timmerman K, Gele P, Petrault M, Bastide M, Laloux C, Moreau C, Bordet R, Devos D, Devedjian JC (2016) Ferroptosis, a newly characterized form of cell death in Parkinson&#x2019;s disease that is regulated by PKC. Neurobiol Dis 94:169&#x2013;178. 10.1016/j.nbd.2016.05.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2016.05.011</ArticleId><ArticleId IdType="pubmed">27189756</ArticleId></ArticleIdList></Reference><Reference><Citation>Drey M, Grosch C, Neuwirth C, Bauer JM, Sieber CC (2013) The Motor Unit Number Index (MUNIX) in sarcopenic patients. Exp Gerontol 48:381&#x2013;384. 10.1016/j.exger.2013.01.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exger.2013.01.011</ArticleId><ArticleId IdType="pubmed">23376626</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedmann Angeli JP, Schneider M, Proneth B, Tyurina YY, Tyurin VA, Hammond VJ, Herbach N, Aichler M, Walch A, Eggenhofer E, Basavarajappa D, Radmark O, Kobayashi S, Seibt T, Beck H, Neff F, Esposito I, Wanke R, Forster H, Yefremova O, Heinrichmeyer M, Bornkamm GW, Geissler EK, Thomas SB, Stockwell BR, O&#x2019;Donnell VB, Kagan VE, Schick JA, Conrad M (2014) Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat Cell Biol 16:1180&#x2013;1191. 10.1038/ncb3064</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb3064</ArticleId><ArticleId IdType="pmc">PMC4894846</ArticleId><ArticleId IdType="pubmed">25402683</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon PH (2013) Amyotrophic Lateral Sclerosis: An update for 2013 Clinical Features, Pathophysiology, Management and Therapeutic Trials. Aging Dis
4:295&#x2013;310. https://doi.org/10.14336%2FAD.2013.0400295</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3794725</ArticleId><ArticleId IdType="pubmed">24124634</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon PH, Moore DH, Miller RG, Florence JM, Verheijde JL, Doorish C, Hilton JF, Spitalny GM, MacArthur RB, Mitsumoto H et al. (2007) Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial. Lancet Neurol 6:1045&#x2013;1053. 10.1016/S1474-4422(07)70270-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(07)70270-3</ArticleId><ArticleId IdType="pubmed">17980667</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD et al. (1994) Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 264:1772&#x2013;1775. 10.1126/science.8209258</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall ED, Andrus PK, Oostveen JA, Fleck TJ, Gurney ME (1998) Relationship of oxygen radical-induced lipid peroxidative damage to disease onset and progression in a transgenic model of familial ALS. J Neurosci Res 53:66&#x2013;77. 10.1002/(SICI)1097-4547(19980701)53:1&lt;66::AID-JNR7&gt;3.0.CO;2-H</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-4547(19980701)53:1&lt;66::AID-JNR7&gt;3.0.CO;2-H</ArticleId><ArticleId IdType="pubmed">9670993</ArticleId></ArticleIdList></Reference><Reference><Citation>Heimer-McGinn V, Young P (2011) Efficient inducible Pan-neuronal cre-mediated recombination in SLICK-H transgenic mice. Genesis 49:942&#x2013;949. 10.1002/dvg.20777</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dvg.20777</ArticleId><ArticleId IdType="pubmed">21671347</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan MC, Vucic S, Talbot K, McDermott CJ, Hardiman O, Shefner JM, Al-Chalabi A, Huynh W, Cudkowicz M, Talman P, Van den Berg LH, Dharmadasa T, Wicks P, Reilly C, Turner MR (2021) Improving clinical trial outcomes in amyotrophic lateral sclerosis. Nat Rev Neurol 17:104&#x2013;118. 10.1038/s41582-020-00434-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-00434-z</ArticleId><ArticleId IdType="pmc">PMC7747476</ArticleId><ArticleId IdType="pubmed">33340024</ArticleId></ArticleIdList></Reference><Reference><Citation>Linkermann A, Skouta R, Himmerkus N, Mulay SR, Dewitz C, De ZF, Prokai A, Zuchtriegel G, Krombach F, Welz PS, Weinlich R, Vanden Berghe T, Vandenabeele P, Pasparakis M, Bleich M, Weinberg JM, Reichel CA, Brasen JH, Kunzendorf U, Anders HJ, Stockwell BR, Green DR, Krautwald S (2014) Synchronized renal tubular cell death involves ferroptosis. Proc Natl Acad Sci U.S.A. 111:16836&#x2013;16841. 10.1073/pnas.1415518111</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1415518111</ArticleId><ArticleId IdType="pmc">PMC4250130</ArticleId><ArticleId IdType="pubmed">25385600</ArticleId></ArticleIdList></Reference><Reference><Citation>Miana-Mena FJ, Mu&#xf1;oz MJ, Yag&#xfc;e G, Mendez M, Moreno M, Ciriza J, Zaragoza P, Osta R (2005) Optimal methods to characterize the G93A mouse model of ALS. Amyotroph Lateral Scler Frontotemporal Degener 6:55&#x2013;62. 10.1080/14660820510026162</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14660820510026162</ArticleId><ArticleId IdType="pubmed">16036427</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen WA, Fu W, Keller JN, Markesbery WR, Appel S, Smith RG, Kasarskis E, Mattson MP (1998) Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients. Ann Neurol 44:819&#x2013;824. 10.1002/ana.410440518</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410440518</ArticleId><ArticleId IdType="pubmed">9818940</ArticleId></ArticleIdList></Reference><Reference><Citation>Perluigi M, Poon HF, Hensley K, Pierce WM, Klein JB, Calabrese V, De Marco C, Butterfield DA (2005) Proteomic analysis of 4-hydroxy-2-nonenal-modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis. Free Radic Biol Med 38:960&#x2013;968. 10.1016/j.freeradbiomed.2004.12.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2004.12.021</ArticleId><ArticleId IdType="pubmed">15749392</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinert RB, Kantz J, Misfeldt AA, Poffenberger G, Gannon M, Brissova M, Powers AC (2012) Tamoxifen-induced Cre-loxP recombination is prolonged in pancreatic islets of adult mice. PloS One 7:e33529. 10.1371/journal.pone.0033529</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0033529</ArticleId><ArticleId IdType="pmc">PMC3314663</ArticleId><ArticleId IdType="pubmed">22470452</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson EP, Henry YK, Henkel JS, Smith RG, Appel SH (2004) Increased lipid peroxidation in sera of ALS patients: a potential biomarker of disease burden. Neurology 62:1758&#x2013;1765. 10.1212/WNL.62.10.1758</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.62.10.1758</ArticleId><ArticleId IdType="pubmed">15159474</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson J, Amor S (2017) Modelling amyotrophic lateral sclerosis in mice. Drug Discov Today Dis Models 25&#x2013;26:35&#x2013;44. 10.3389/fnmol.2020.00093</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2020.00093</ArticleId></ArticleIdList></Reference><Reference><Citation>Weydt P, Hong SY, Kliot M, M&#xf6;ller T (2003) Assessing disease onset and progression in the SOD1 mouse model of ALS. Neuroreport 14:1051&#x2013;1054. 10.1097/01.wnr.0000073685.00308.89</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.wnr.0000073685.00308.89</ArticleId><ArticleId IdType="pubmed">12802201</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, Cheah JH, Clemons PA, Shamji AF, Clish CB, Brown LM, Girotti AW, Cornish VW, Schreiber SL, Stockwell BR (2014) Regulation of ferroptotic cancer cell death by GPX4. Cell 156:317&#x2013;331. 10.1016/j.cell.2013.12.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.12.010</ArticleId><ArticleId IdType="pmc">PMC4076414</ArticleId><ArticleId IdType="pubmed">24439385</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang WS, Stockwell BR (2016) Ferroptosis: death by lipid peroxidation. Trends Cell Biol 26:165&#x2013;176. 10.1016/j.tcb.2015.10.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2015.10.014</ArticleId><ArticleId IdType="pmc">PMC4764384</ArticleId><ArticleId IdType="pubmed">26653790</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo SE, Chen L, Na R, Liu Y, Rios C, Van RH, Richardson A, Ran Q (2012) Gpx4 ablation in adult mice results in a lethal phenotype accompanied by neuronal loss in brain. Free Radic Biol Med 52:1820&#x2013;1827. 10.1016/j.freeradbiomed.2012.02.043</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2012.02.043</ArticleId><ArticleId IdType="pmc">PMC3341497</ArticleId><ArticleId IdType="pubmed">22401858</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Go YM, Jones DP (2007) Mitochondrial thioredoxin-2/peroxiredoxin-3 system functions in parallel with mitochondrial GSH system in protection against oxidative stress. Arch Biochem Biophys 465:119&#x2013;126. 10.1016/j.abb.2007.05.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.abb.2007.05.001</ArticleId><ArticleId IdType="pubmed">17548047</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>